Biological pathways and networks implicated in psychiatric disorders

Current Opinion in Behavioral Sciences

Volumn 2, Issue , 2015, Pages 58-68

  Sullivan, Patrick F ^a,b   Posthuma, Danielle ^c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEUROTRANSMISSION; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84922652086     PISSN: None     EISSN: 23521546     Source Type: Journal    
DOI: 10.1016/j.cobeha.2014.09.003     Document Type: Review

References (90)

1. Eaton W.W., Martins S.S., Nestadt G., Bienvenu O.J., Clarke D., Alexandre P. The burden of mental disorders. Epidemiol Rev 2008, 30:1-14.
2. Buka S.L. Psychiatric epidemiology: reducing the global burden of mental illness. Am J Epidemiol 2008, 168:977-979.
3. Hettema J.M., Neale M.C., Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001, 158:1568-1578.
4. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192.
5. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
6. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
7. Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., Perlis R.H., Mowry B.J., Thapar A., Goddard M.E., Witte J.S., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994.
8. Sullivan P.F., Daly M.J., O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012, 13:537-551.
9. Akil H., Brenner S., Kandel E., Kendler K.S., King M-C., Scolnick E., Watson J.D., Zoghbi H.Y. Medicine. The future of psychiatric research: genomes and neural circuits. Science 2010, 327:1580-1581.
10. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
11. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
12. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
13. Gratten J., Visscher P.M., Mowry B.J., Wray N.R. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat Genet 2013, 45:234-238.
14. Veltman J.A., Brunner H.G. De novo mutations in human genetic disease. Nat Rev Genet 2012, 13:565-575.
15. Buxbaum J.D., Daly M.J., Devlin B., Lehner T., Roeder K., State M.W. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 2012, 76:1052-1056.
16. McGrath J.J., Mortensen P.B., Visscher P.M., Wray N.R. Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophr Bull 2013, 39:955-959.
17. Psychiatric Genomics Consortium Schizophrenia Working Group Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
18. Lander E.S. Initial impact of the sequencing of the human genome. Nature 2011, 470:187-197.
19. Stahl E.A., Wegmann D., Trynka G., Gutierrez-Achury J., Do R., Voight B.F., Kraft P., Chen R., Kallberg H.J., Kurreeman F.A.S., et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 2012, 44:483-489.
20. Fingerlin T.E., Murphy E., Zhang W., Peljto A.L., Brown K.K., Steele M.P., Loyd J.E., Cosgrove G.P., Lynch D., Groshong S., et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013, 45:613-620.
21. Bradfield J.P., Taal H.R., Timpson N.J., Scherag A., Lecoeur C., Warrington N.M., Hypponen E., Holst C., Valcarcel B., Thiering E., et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet 2012, 44:526-531.
22. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., Willer C.J., Jackson A.U., Vedantam S., Raychaudhuri S., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
23. Berndt S.I., Skibola C.F., Joseph V., Camp N.J., Nieters A., Wang Z., Cozen W., Monnereau A., Wang S.S., Kelly R.S., et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013, 45:868-876.
24. Bønnelykke K., Matheson M.C., Pers T.H., Granell R., Strachan D.P., Alves A.C., Linneberg A., Curtin J.A., Warrington N.M., Standl M., et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet 2013, 45:902-906.
25. Wang K., Li M., Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010, 11:843-854.
26. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
27. Lips E.S., Cornelisse L.N., Toonen R.F., Min J.L., Hultman C.M., Holmans P.A., O'Donovan M.C., Purcell S.M., Smit A.B., Verhage M., et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012, 17:996-1006.
28. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011, 16:286-292.
29. Goudriaan A., de Leeuw C., Ripke S., Hultman C.M., Sklar P., Sullivan P.F., Smit A.B., Posthuma D., Verheijen M.H.G. Specific glial functions contribute to schizophrenia susceptibility. Schizophr Bull 2013, 40:925-935.
30. Duncan L.E., Holmans P.A., Lee P.H., O'Dushlaine C.T., Kirby A.W., Smoller J.W., Öngür D., Cohen B.M. Pathway analyses implicate glial cells in schizophrenia. PLOS ONE 2014, 9:e89441.
31. Yu H., Bi W., Liu C., Zhao Y., Zhang D., Yue W. A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014, 51:140-145.
32. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012, 17:142-153.
33. Szatkiewicz J.P., O'Dushlaine C., Chen G., Chambert K., Moran J.L., Neale B.M., Fromer M., Ruderfer D., Akterin S., Bergen S.E., et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry 2014, 19:762-773.
34. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kähler A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
35. Hussman J.P., Chung R-H., Griswold A.J., Jaworski J.M., Salyakina D., Ma D., Konidari I., Whitehead P.L., Vance J.M., Martin E.R., et al. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism 2011, 2:1.
36. Prasad A., Merico D., Thiruvahindrapuram B., Wei J., Lionel A.C., Sato D., Rickaby J., Lu C., Szatmari P., Roberts W., et al. A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3 (Bethesda) 2012, 2:1665-1685.
37. Poultney C.S., Goldberg A.P., Drapeau E., Kou Y., Harony-Nicolas H., Kajiwara Y., De Rubeis S., Durand S., Stevens C., Rehnström K., et al. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am J Hum Genet 2013, 93:607-619.
38. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
39. Martin J., Cooper M., Hamshere M.L., Pocklington A., Scherer S.W., Kent L., Gill M., Owen M.J., Williams N., O'Donovan M.C., et al. Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. J Am Acad Child Adolesc Psychiatry 2014, 53. 761-770.e26.
40. Pinto D., Delaby E., Merico D., Barbosa M., Merikangas A., Klei L., Thiruvahindrapuram B., Xu X., Ziman R., Wang Z., et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet 2014, 94:677-694.
41. An J.Y., Cristino A.S., Zhao Q., Edson J., Williams S.M., Ravine D., Wray J., Marshall V.M., Hunt A., Whitehouse A.J.O., et al. Towards a molecular characterization of autism spectrum disorders: an exome sequencing and systems approach. Transl Psychiatry 2014, 4:e394.
42. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C-F., Stevens C., Wang L-S., Makarov V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
43. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
44. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
45. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y-H., Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
46. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
47. Willsey A.J., Sanders S.J., Li M., Dong S., Tebbenkamp A.T., Muhle R.A., Reilly S.K., Lin L., Fertuzinhos S., Miller J.A., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013, 155:997-1007.
48. Xu W., Cohen-Woods S., Chen Q., Noor A., Knight J., Hosang G., Parikh S.V., De Luca V., Tozzi F., Muglia P., et al. Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet 2014, 15:2.
49. Chuang L-C., Kao C-F., Shih W-L., Kuo P-H. Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder. PLOS ONE 2013, 8:e53092.
50. Pandey A., Davis N.A., White B.C., Pajewski N.M., Savitz J., Drevets W.C., McKinney B.A. Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder. Transl Psychiatry 2012, 2:e154.
51. Torkamani A., Topol E.J., Schork N.J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008, 92:265-272.
52. Nurnberger J.I., Koller D.L., Jung J., Edenberg H.J., Foroud T., Guella I., Vawter M.P., Kelsoe J.R. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014, 71:657-664.
53. Holmans P., Green E.K., Pahwa J.S., Ferreira M.A.R., Purcell S.M., Sklar P., Owen M.J., O'Donovan M.C., Craddock N. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009, 85:13-24.
54. Shih W-L., Kao C-F., Chuang L-C., Kuo P-H. Incorporating information of microRNAs into pathway analysis in a genome-wide association study of bipolar disorder. Front Genet 2012, 3:293.
55. Pedroso I., Lourdusamy A., Rietschel M., Nöthen M.M., Cichon S., McGuffin P., Al-Chalabi A., Barnes M.R., Breen G. Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes. Biol Psychiatry 2012, 72:311-317.
56. Le-Niculescu H., Patel S.D., Bhat M., Kuczenski R., Faraone S.V., Tsuang M.T., McMahon F.J., Schork N.J., Nurnberger J.I., Niculescu A.B. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B: Neuropsychiatr Genet 2009, 150B:155-181.
57. PGC-BIP Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011, 43:977-983.
58. O'Dushlaine C., Ripke S., Ruderfer D.M., Hamilton S.P., Fava M., Iosifescu D.V., Kohane I.S., Churchill S.E., Castro V.M., Clements C.C., et al. Rare copy number variation in treatment-resistant major depressive disorder. Biol Psychiatry 2014, 10.1016/j.biopsych.2013.10.028.
59. Jia P., Kao C-F., Kuo P-H., Zhao Z. A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Syst Biol 2011, 5(Suppl 3):S12.
60. Kao C-F., Jia P., Zhao Z., Kuo P-H. Enriched pathways for major depressive disorder identified from a genome-wide association study. Int J Neuropsychopharmacol 2012, 15:1401-1411.
61. Song G.G., Kim J-H., Lee Y.H. Genome-wide pathway analysis in major depressive disorder. J Mol Neurosci 2013, 51:428-436.
62. Lee Y.H., Song G.G. Genome-wide pathway analysis in attention-deficit/hyperactivity disorder. Neurol Sci 2014, 10.1007/s10072-014-1671-2.
63. Yang L., Neale B.M., Liu L., Lee S.H., Wray N.R., Ji N., Li H., Qian Q., Wang D., Li J., et al. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B: Neuropsychiatr Genet 2013, 162B:419-430.
64. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., Hawi Z., Kent L., Gill M., Williams N., Owen M.J., et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012, 169:186-194.
65. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
66. Wang K., Li M., Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007, 81:1278-1283.
67. Rossin E.J., Lage K., Raychaudhuri S., Xavier R.J., Tatar D., Benita Y., Cotsapas C., Daly M.J. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011, 7:e1001273.
68. Feldman I., Rzhetsky A., Vitkup D. Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A 2008, 105:4323-4328.
69. Ruano D., Abecasis G.R., Glaser B., Lips E.S., Cornelisse L.N., de Jong A.P.H., Evans D.M., Davey Smith G., Timpson N.J., Smit A.B., et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet 2010, 86:113-125.
70. Jungerius B.J., Hoogendoorn M.L.C., Bakker S.C., Van't Slot R., Bardoel A.F., Ophoff R.A., Wijmenga C., Kahn R.S., Sinke R.J. An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry 2008, 13:1060-1068.
71. Cristino A.S., Williams S.M., Hawi Z., An J-Y., Bellgrove M.A., Schwartz C.E., Costa L.da F., Claudianos C. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry 2014, 19:294-301.
72. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y.S., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
73. Bindea G., Mlecnik B., Hackl H., Charoentong P., Tosolini M., Kirilovsky A., Fridman W-H., Pagès F., Trajanoski Z., Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25:1091-1093.
74. Erten S., Bebek G., Ewing R.M., Koyutürk M. DADA: Degree-Aware Algorithms for Network-Based Disease Gene Prioritization. BioData Min 2011, 4:19.
75. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
76. Chen E.Y., Tan C.M., Kou Y., Duan Q., Wang Z., Meirelles G.V., Clark N.R., Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 2013, 14:128.
77. Ideker T., Dutkowski J., Hood L. Boosting signal-to-noise in complex biology: prior knowledge is power. Cell 2011, 144:860-863.
78. Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38:W214-W220.
79. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010, 28:495-501.
80. Zhang K., Chang S., Cui S., Guo L., Zhang L., Wang J. ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework. Nucleic Acids Res 2011, 39:W437-W443.
81. Lee P.H., O'Dushlaine C., Thomas B., Purcell S.M. INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012, 28:1797-1799.
82. Aranda B., Achuthan P., Alam-Faruque Y., Armean I., Bridge A., Derow C., Feuermann M., Ghanbarian A.T., Kerrien S., Khadake J., et al. The IntAct molecular interaction database in 2010. Nucleic Acids Res 2010, 38:D525-D531.
83. Segrè A.V., Groop L., Mootha V.K., Daly M.J., Altshuler D. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 2010, 6.
84. Eberle M.A., Ng P.C., Kuhn K., Zhou L., Peiffer D.A., Galver L., Viaud-Martinez K.A., Lawley C.T., Gunderson K.L., Shen R., et al. Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genet 2007, 3:1827-1837.
85. Ceol A., Chatr Aryamontri A., Licata L., Peluso D., Briganti L., Perfetto L., Castagnoli L., Cesareni G. MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 2010, 38:D532-D539.
86. Stark C., Breitkreutz B-J., Chatr-Aryamontri A., Boucher L., Oughtred R., Livstone M.S., Nixon J., Van Auken K., Wang X., Shi X., et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 2011, 39:D698-D704.
87. O'Dushlaine C., Kenny E., Heron E.A., Segurado R., Gill M., Morris D.W., Corvin A. The SNP ratio test: pathway analysis of genome-wide association datasets. Bioinformatics 2009, 25:2762-2763.
88. Raychaudhuri S., Korn J.M., McCarroll S.A., Altshuler D., Sklar P., Purcell S., Daly M.J. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 2010, 6:e1001097.
89. Li M-X., Kwan J.S.H., Sham P.C. HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis. Am J Hum Genet 2012, 91:478-488.
90. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-W748.